Patient Reported Outcomes of NRG Oncology/RTOG 0232: A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with Brachytherapy Alone in Intermediate Risk Prostate Cancer

To assess differences in patient (pt)-reported outcomes (PROs) between combined external beam therapy (EBT) and transperineal interstitial permanent brachytherapy (B) among pts with intermediate risk prostate cancer (PC). The primary endpoint reported that the addition of EBT to B did not result in superior PFS compared to B alone. Men with intermediate risk PC were randomized to either 45 Gy partial pelvis EBT+B or B alone. The Expanded...